Chronic Hepatitis C virus infection in Swiss primary care practices: Low case loads-high barriers to treatment?

被引:4
作者
Overbeck, Kathrin [2 ]
Bruggmann, Philip [3 ]
Helbling, Beat [1 ]
机构
[1] Stadtspital Waid, Dept Gastroenterol & Hepatol, CH-8037 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Internal Med, Zurich, Switzerland
[3] ARUD Assoc Risk Reduct Drugs, Zurich, Switzerland
关键词
Hepatitis C; primary care physician; disease workup; patient monitoring; barriers to treatment; THERAPY; MANAGEMENT; PREDICTORS; PHYSICIANS; PATIENT; RATES;
D O I
10.3109/13814788.2010.545122
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The primary care physician (PCP) diagnoses chronic Hepatitis C virus (HCV) infection in most patients. He serves as gatekeeper and plays a key role in counselling and treatment guidance. Objectives: To calculate the approximate HCV caseload per practice and characterize PCPs management of the disease; in particular, to determine antiviral treatment rates and reasons for PCPs for withholding treatment. The ultimate objective was to identify potentially modifiable barriers to treatment. Methods: A confidential self-administered questionnaire centred on the above-mentioned questions was distributed to 2371 Swiss primary care physicians. All respondents of the main questionnaire received an additional small questionnaire focussed on the initial disease workup. Descriptive statistics were used to describe questionnaire responses and PCP demographics. Results : The response rate was 53.1%. Of all participating PCPs (n = 1084), 86.2% reported having patients with chronic HCV, with an average number of 4 patients per practice; 18.6% (n = 142) of PCPs did not monitor their chronic HCV patients. Two-thirds (66.8%) of the sample chronic HCV patient population (n = 4626) never received antiviral therapy. The main reasons given by PCPs for withholding treatment were HCV-specialist advice, patient preference, normal liver enzymes and patient related factors like substance abuse or psychiatric co morbidity. Conclusions: Most PCPs follow patients with chronic hepatitis C, but practice caseloads are low, which may account for insecurity in managing this complex disease.
引用
收藏
页码:103 / 108
页数:6
相关论文
共 50 条
  • [31] Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement
    Artenie, A. A.
    Jutras-Aswad, D.
    Roy, E.
    Zang, G.
    Bamvita, J. -M.
    Levesque, A.
    Bruneau, J.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (10) : 792 - 799
  • [32] Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study
    Treloar, C.
    Rance, J.
    Dore, G. J.
    Grebely, J.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 (08) : 560 - 567
  • [33] Determinants of successful chronic hepatitis C case finding among patients receiving opioid maintenance treatment in a primary care setting
    Senn, Oliver
    Seidenberg, Andre
    Rosemann, Thomas
    ADDICTION, 2009, 104 (12) : 2033 - 2038
  • [34] Low-Dose Cyclosporine A in the Treatment of Severe Atopic Dermatitis Complicated by Chronic Hepatitis C Virus Infection
    Gnarra, Maria
    De Simone, Clara
    Garcovich, Matteo
    Garcovich, Simone
    PEDIATRIC DERMATOLOGY, 2017, 34 (03) : 374 - 376
  • [35] Treatment of chronic hepatitis C virus infection:: we must target the virus or liver fibrosis?
    Soriano, V
    Martín-Carbonero, L
    García-Samaniego, J
    AIDS, 2003, 17 (05) : 751 - 753
  • [36] Association of NKG2A with treatment for chronic hepatitis C virus infection
    Harrison, R. J.
    Ettorre, A.
    Little, A. -M.
    Khakoo, S. I.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 161 (02) : 306 - 314
  • [37] HIV Infection Status as a Predictor of Hepatitis C Virus RNA Testing in Primary Care
    Yartel, Anthony K.
    Morgan, Rebecca L.
    Rein, David B.
    Brown, Kimberly Ann
    Kil, Natalie B.
    Massoud, Omar I.
    Fallon, Michael B.
    Smith, Bryce D.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2015, 49 (03) : 423 - 427
  • [38] Screening, Linkage to Care and Treatment of Hepatitis C Infection in Primary Care Setting in the South of Italy
    Citarella, Anna
    Cammarota, Simona
    Bernardi, Francesca F.
    Coppola, Carmine
    D'Anto, Maria
    Fogliasecca, Marianna
    Giusto, Elio
    Masarone, Mario
    Megna, Angelo Salomone
    Sellitto, Carmine
    Servodio, Rosa
    Smaldone, Massimo
    Staiano, Laura
    Trama, Ugo
    Conti, Valeria
    Persico, Marcello
    LIFE-BASEL, 2020, 10 (12): : 1 - 9
  • [39] Pretreatment serum microRNA-122 is not predictive for treatment response in chronic hepatitis C virus infection
    Waidmann, Oliver
    Bihrer, Verena
    Kronenberger, Bernd
    Zeuzem, Stefan
    Piiper, Albrecht
    Forestier, Nicole
    DIGESTIVE AND LIVER DISEASE, 2012, 44 (05) : 438 - 441
  • [40] Low prevalence of necrolytic acral erythema in patients with chronic hepatitis C virus infection
    Raphael, Brian A.
    Dorey-Stein, Zachariah L.
    Lott, Jason
    Amorosa, Valerianna
    Lo Re, Vincent, III
    Kovarik, Carrie
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (05) : 962 - 968